What Merck & Co Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 17 | 35 |
| Total trades | 25 | 91 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 126,480 | 513,913 |
| Disposed | 228,238 | 607,947 |
| Net activity | −101,758 | −94,034 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Guindo Chirfi | EVP, Access, Policy & Comms | Aug 13 | Open-market sale · S | −10,000 | $135.00 | −$1.35M | 36,613 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 12 | Open-market sale · S | −600 | $132.04 | −$79.2K | 110,167 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 12 | Open-market sale · S | −11,099 | $131.61 | −$1.46M | 110,767 |
| Zachary Jennifer | EVP, General Counsel | Aug 12 | Open-market sale · S | −80,315 | $133.46 | −$10.7M | 45,509 |
| Zachary Jennifer | EVP, General Counsel | Aug 12 | Exercise / conversion · M | +13,433 | $84.71 | +$1.14M | 125,824 |
| Zachary Jennifer | EVP, General Counsel | Aug 12 | Exercise / conversion · M | +41,494 | $117.89 | +$4.89M | 112,391 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 11 | Open-market sale · S | −5,427 | $132.35 | −$718K | 121,866 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 11 | Open-market sale · S | −7,410 | $131.33 | −$973K | 127,293 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 10 | Open-market sale · S | −20,784 | $130.43 | −$2.71M | 134,703 |
| Guindo Chirfi | EVP, Access, Policy & Comms | Aug 06 | Open-market sale · S | −15,000 | $131.00 | −$1.97M | 46,613 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 06 | Open-market sale · S | −300 | $131.02 | −$39.3K | 155,487 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 06 | Open-market sale · S | −4,945 | $130.23 | −$644K | 155,787 |
| DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Aug 06 | Open-market sale · S | −805 | $131.02 | −$105K | 160,732 |
| Williams David Michael | EVP,Chief Info&Digital Officer | Aug 05 | Open-market sale · S | −34,705 | $128.77 | −$4.47M | 31,716 |
| Williams David Michael | EVP,Chief Info&Digital Officer | Aug 05 | Exercise / conversion · M | +34,705 | $73.73 | +$2.56M | 66,421 |
| Williams David Michael | EVP,Chief Info&Digital Officer | Aug 05 | Open-market sale · S | −13,542 | $128.77 | −$1.74M | 31,716 |
| Williams David Michael | EVP,Chief Info&Digital Officer | Aug 05 | Exercise / conversion · M | +13,542 | $75.36 | +$1.02M | 45,258 |
| Williams David Michael | EVP,Chief Info&Digital Officer | Aug 05 | Open-market sale · S | −4,600 | $128.77 | −$592K | 31,716 |
| Williams David Michael | EVP,Chief Info&Digital Officer | Aug 05 | Exercise / conversion · M | +4,600 | $77.62 | +$357K | 36,316 |
| Maraldo David R. | EVP & Pres. MMD | Aug 05 | Open-market sale · S | −2,686 | $128.72 | −$346K | 18,212 |
Loading...
